EzHomeo and HomeoGPT: evaluate an offer, not a launch date
HomeoGPT’s public FAQ still describes a limited beta and a planned Q1 2024 release.
Evaluating EzHomeo? Start a reviewable consultation in the app. 10 consultation credits free, no card required.
Published by EzHomeo. We make one of the products compared.
Why a practitioner might investigate HomeoGPT
HomeoGPT says its system draws on Dr. Samit Ghosh’s case archive and names repertory and materia medica sources. It describes follow-up questions about why a remedy was suggested and a configurable priority among sources.
The same public FAQ says users can type or dictate symptoms, describes limited beta testing and monthly and annual subscriptions without prices, and still mentions a Q1 2024 general release.
EzHomeo has a published purchase path now
EzHomeo’s site lists 10 starter consultation credits without a card, ₹999/month and ₹29,999 lifetime. Its published workflow begins with practitioner-controlled consultation recording, followed by transcript review and editable rubric suggestions, not just a typed symptom description.
If source-priority controls or questions about proposed remedies matter, request a HomeoGPT demo. If a priced consultation-capture plan matters now, inspect EzHomeo’s current checkout and test its review controls.
To assess the available EzHomeo path, open the app and start today.
Status as of 28 September 2026
HomeoGPT’s public FAQ described a limited beta on 28 September 2026. EzHomeo is available today with 10 starter consultation credits and no card required.
- Access
- Can you obtain a working account now?
- Demonstration
- Can you inspect the proposed workflow?
- Terms
- What plan and support are offered today?
- Evidence date
- Record when each answer was confirmed
Compare an available trial with a current demo
Try EzHomeo’s review workflow and ask HomeoGPT for its current access and a live demonstration.
Sources and further reading
Last checked .